| Literature DB >> 31820177 |
Yani Liu1, KeWei Wang2.
Abstract
Ion channels are macromolecular proteins that form water-filled pores in cell membranes and they are critical for a variety of physiological and pharmacological functions. Dysfunctional ion channels can cause diseases known as channelopathies. Ion channels are encoded by approximately 400 genes, representing the second largest class of proven drug targets for therapeutic areas including neuropsychiatric disorders, cardiovascular and metabolic diseases, immunological diseases, nephrological diseases, gastrointestinal diseases, pulmonary/respiratory diseases, and many cancers. With more ion channel structures are being solved and functional robust assays are being developed, there are tremendous opportunities for identifying specific modulators targeting ion channels for new therapy.Entities:
Keywords: ANO1; Arrhythmia; BK; CFTR; Cancer; Channelopathy; Drug target; Epilepsy; GABA; KCNQ; Kir; Kv7; LRRC8A; Nav; Pain; TMEM16A; hERG
Year: 2019 PMID: 31820177 DOI: 10.1007/164_2019_333
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004